1
SIMPLY OYAVAS®
AN ANTI-VEGF MONOCLONAL ANTIBODY
SIMPLY CONVINCING
Similar efficacy, safety and quality to the reference product
Indicated for the treatment of the same cancer types as the reference product
*2
* † 1,3
SIMPLY DEDICATED
Over 20 years of experience in biosimilars
‡
SIMPLY RELIABLE
Manufactured in Spain
2
VEGF, vascular endothelial growth factor *Avastin® †Not all treatment schedules within each cancer type are approved due to patent protection ‡STADA founded Bioceuticals Arzneimittel AG in 2000 1. Oyavas® SmPC (Apr. 2021). 2. Oyavas® EPAR Public Assessment Report. Available at: https://www.ema.europa.eu/en/documents/ assessment-report/oyavas-epar-public-assessment-report_en.pdf. Last accessed May 2021. 3. Avastin® SmPC (Feb. 2021).
SIMPLY CONVINCING
OYAVAS® HAS SIMILAR EFFICACY AND SAFETY TO THE REFERENCE PRODUCT *
1
*Avastin® 1. Results from the STELLA study: Trukhin D, et al. BioDrugs 2021. Available at: https://doi.org/10.1007/s40259-021-00483-w. Last accessed May 2021. Oyavas® EPAR Public Assessment Report. Available at: https://www.ema.europa.eu/en/documents/assessment-report/oyavas-epar-public-assessment-report_en.pdf. Last accessed May 2021. CI, confidence interval
†Patients with newly diagnosed/recurrent non-squamous NSCLC (non-small cell lung cancer), stage IIIb/IV
SIMPLY DEDICATED
CLONMEL HEALTHCARE IS A MEMBER OF THE STADA GROUP
CARING FOR PEOPLE'S HEALTH AS A TRUSTED PARTNER
We have been manufacturing
and distributing pharmaceuticals
for more than 125 years
Long-standing history in serving
patients and physicians with high-quality pharmaceutical products
Safety is our priority: we ensure
that the safety and efficacy of our
products are never compromised
MAKING EFFECTIVE MEDICINE ACCESSIBLE
Over 20 years of experience in
biosimilars*
Building on the innovation of biologics, providing lower-priced
alternatives to the reference
products
Making biologics available to more patients for more than ten years
*STADA founded Bioceuticals Arzneimittel AG in 2000
SIMPLY RELIABLE
OYAVAS® IS MANUFACTURED IN THE EU
1
All manufacturing steps take place in Spain for a strong and reliable EU supply chain
1. Oyavas® EPAR Public Assessment Report. Available at: https://www.ema.europa.eu/en/documents/assessment-report/oyavas-epar-public-assessment-report_en.pdf. Last accessed May 2021.